InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Colgan Erin, 首席财务官. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. Cumulatively, 5 disclosures have been published. Activity tracked since 15 February 2022. The latest transaction was filed on 15 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Colgan Erin is Directeur Financier at Sensei Biotherapeutics, Inc. (CHIEF FINANCIAL OFFICER). The declarant has 5 filings in total, and over the sampled recent filings from 2022-02-17 to 2024-02-16, the recorded transactions are all of the Attribution type, with buy and sell amounts at 0 EUR.